Cencora, Inc. (COR) To Go Ex-Dividend on February 13th

Cencora, Inc. (NYSE:COR) announced a quarterly dividend on Wednesday, February 4th. Shareholders of record on Friday, February 13th will be given a dividend of 0.60 per share on Monday, March 2nd. This represents a c) dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, February 13th.

Cencora has raised its dividend by an average of 0.1%annually over the last three years and has increased its dividend annually for the last 15 consecutive years. Cencora has a dividend payout ratio of 13.9% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Cencora to earn $16.88 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 14.2%.

Cencora Stock Down 0.9%

Shares of COR opened at $360.00 on Wednesday. The firm has a fifty day moving average price of $346.17 and a 200-day moving average price of $327.39. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The firm has a market capitalization of $69.84 billion, a P/E ratio of 43.27, a P/E/G ratio of 1.67 and a beta of 0.68. Cencora has a 12-month low of $237.71 and a 12-month high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. The company had revenue of $85.93 billion during the quarter, compared to analyst estimates of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter last year, the business posted $3.73 EPS. Equities research analysts expect that Cencora will post 15.37 earnings per share for the current year.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.